Fairvalue-Calculator Fairvalue-Calculator
EN DE

NexgenRx Inc (NXG) Fair Value & Analysis

Energy · CA · Market cap A$10.6B

PriceA$14.50
Fair ValueA$4.99
Upside-65.6%
Quality95/100
Evidence: Low Range A$3.74 – A$6.24

Analysis

NexgenRx Inc (NXG) currently trades at A$14.50, while our model-based Fair Value estimate is A$4.99 — implying the stock looks roughly 65.6% overvalued today. We read business quality at 95/100 (high quality), in the Energy sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Open the full interactive analysis →

Similar stocks

National Atomic Company (KAP) -31% Cameco Corporation (CCJ) -91% China National Uranium Co (001280) -84% NexGen Energy Ltd (NXE) -71% Uranium Energy Corp (UEC) -96% Sprott Physical Uranium Trust Fund (UU) +60%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.